These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26167698)

  • 21. Practical approach to non-alcoholic fatty liver disease in patients with diabetes.
    Tai FW; Syn WK; Alazawi W
    Diabet Med; 2015 Sep; 32(9):1121-33. PubMed ID: 25683343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Alcoholic Fatty Liver Disease in HIV Infection.
    Macías J; Pineda JA; Real LM
    AIDS Rev; 2017; 19(1):35-46. PubMed ID: 28182612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical guidelines of non-alcoholic fatty liver disease: A systematic review.
    Zhu JZ; Hollis-Hansen K; Wan XY; Fei SJ; Pang XL; Meng FD; Yu CH; Li YM
    World J Gastroenterol; 2016 Sep; 22(36):8226-33. PubMed ID: 27688665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology].
    Caballería L; Saló J; Berzigotti A; Planas R; Vila C; Huertas C; Torres M; Torán P; Caballería J;
    Gastroenterol Hepatol; 2014; 37(6):372-83. PubMed ID: 24746904
    [No Abstract]   [Full Text] [Related]  

  • 25. [[The Modern View on Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease].].
    Podymova SD
    Eksp Klin Gastroenterol; 2016; (5):74-82. PubMed ID: 28614648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity].
    Felber J; Aust D; Baas S; Bischoff S; Bläker H; Daum S; Keller R; Koletzko S; Laass M; Nothacker M; Roeb E; Schuppan D; Stallmach A
    Z Gastroenterol; 2014 Jul; 52(7):711-43. PubMed ID: 25026010
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
    Yki-Järvinen H
    Lancet Diabetes Endocrinol; 2014 Nov; 2(11):901-10. PubMed ID: 24731669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 29. [Strengthen researches on risk factors and early diagnosis of nonalcoholic fatty liver].
    Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):805-7. PubMed ID: 24516924
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment.
    Argyrou C; Moris D; Vernadakis S
    J BUON; 2017; 22(1):6-20. PubMed ID: 28365930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.
    Abenavoli L; Milic N; Peta V; Alfieri F; De Lorenzo A; Bellentani S
    World J Gastroenterol; 2014 Dec; 20(45):16831-40. PubMed ID: 25492997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-alcoholic fatty liver diseases].
    Roeb E; Steffen HM; Bojunga J
    Dtsch Med Wochenschr; 2015 Dec; 140(24):1846. PubMed ID: 26625237
    [No Abstract]   [Full Text] [Related]  

  • 34. [The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity].
    Чубірко КІ
    Wiad Lek; 2017; 70(2):208-212. PubMed ID: 28511161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Position paper of the professional societies to apply recommendation of endoscopic biliodigestive diversion in Germany - DDG / DGAV / DGVS -].
    Siegel E; Kähler G; Schepp W
    Z Gastroenterol; 2014 Jun; 52(6):606-12. PubMed ID: 24905114
    [No Abstract]   [Full Text] [Related]  

  • 36. A REVIEW OF INTERNATIONAL AND NATIONAL CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT-OF NONALCOHOLIC FATTY LIVER DISEASE.
    Golovanova EV; Lazebnik LB
    Eksp Klin Gastroenterol; 2016; (11):76-83. PubMed ID: 29889450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paediatric non-alcoholic fatty liver disease: an overview.
    AlKhater SA
    Obes Rev; 2015 May; 16(5):393-405. PubMed ID: 25753407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.
    Glen J; Floros L; Day C; Pryke R;
    BMJ; 2016 Sep; 354():i4428. PubMed ID: 27605111
    [No Abstract]   [Full Text] [Related]  

  • 39. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
    Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
    Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and future treatment options in non-alcoholic steatohepatitis (NASH).
    Lazaridis N; Tsochatzis E
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):357-369. PubMed ID: 28276821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.